繁體版 / 簡體版
 
ABOUT US
/ OVERVIEW

OVERVIEW

    MICROBIO, which was founded in 2000, has experienced over a decade of growth and remains dedicated to “novel therapeutics development and human lifestyle improvement”. MICROBIO Group’s approach to innovative and responsible drug development has led to two successful drug approvals by the Taiwanese Food and Drug Administration (TFDA). In addition to drug development, we have expanded into other markets such as top-line medical devices, functional health foods, organic agricultural products, and biotechnology venture capital. We always welcome strategic collaborations with leading research institutions, international pharmaceutical companies, and novel biotechnology platforms, all of which allow us to bridge gaps in medical treatments. It is our mission to fulfill unmet healthcare needs, and transform scientific breakthroughs into clinical research in the hopes of providing new treatment options for patients. Our core values, modesty and innovation, drive us to take initiative, stay competitive, and position us as an influential leader in the global market.


好玩棋牌 炒股炒亏了60万想死了 广东快乐十分走势图表彩经网 五粮液股票行情 11运夺金稳赚方法 3d福彩乐彩论坛 支付宝购买股票流程图 山西快乐10分前三遗漏 真钱棋牌游戏20元提现 百度理财亏本金案例 广西11选5哈